Organic tricyclic compounds
AssigneeSumitomo Chemical Company, Limited
InventorsMakoto Sunagawa, Hiromi Sato, Junki Katsube, Hisao Yamamoto
Life of this patent
Estimating the term…
Loading patent…
AssigneeSumitomo Chemical Company, Limited
InventorsMakoto Sunagawa, Hiromi Sato, Junki Katsube, Hisao Yamamoto
Estimating the term…
Novel 9-aminoalkyl-methanoanthracenes of the formula: ##STR1## wherein A is C.sub.1 -C.sub.4 alkylene or C.sub.3 -C.sub.4 alkenylene and R.sub.1 and R.sub.2 are each hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.3 -C.sub.4 alkenyl, C.sub.3 -C.sub.4 alkynyl, C.sub.3 -C.sub.6 cycloalkyl(C.sub.1 -C.sub.3)alkyl, ar(C.sub.1 -C.sub.3)alkyl or polyhalo(C.sub.2 -C.sub.4)alkyl or, when taken together with the adjacent nitrogen atom, they may form a 5 to 7-membered nitrogen-containing heterocyclic ring which may contain an additional hetero atom, and their non-toxic salts, which are useful as anti-anxiety, anti-depressant, major tranquilizer, anti-histamine and anti-allergy drugs and can be prepared through a novel key intermediate, i.e., 9-formyl-9,10-dihydro-9,10-methanoanthracene, by various methods.
A compound of the formula:
9-.gamma.-Methylaminopropyl-9,10-dihydro-9,10-methanoanthracene and or a non-toxic pharmaceutically acceptable salt.
9-.gamma.-Dimethylaminopropyl-9,10-dihydro-9,10-methanoanthracene and or a non-toxic pharmaceutically acceptable salt.
Dependencies are inferred from the claim text.